Previous sessionNext session Focus on prescription drugs II Central square 2 (C2) In programme Friday, 25 October, 2019 - 10:45 to 12:15 View presentations Chair JonesChristopher Senior Advisor and Director of Strategy and InnovationNational Center for Injury Prevention and Control, U.S. Centers for Disease Control and PreventionUnited States Presentations Plenary session Poster session Big debate Structured session Workshop Oral presentation session Short communication session Poster guided tour Friday, 25 October 10:55 Oral presentation Investigating cognitive function among people with chronic non-cancer pain prescribed opioids: a longitudinal study 10:55 to 11:05 Central square 2 (C2) Jane Akhurst 11:05 Oral presentation Additional prescription of benzodiazepines, z-drugs and gabapentoids and mortality risk in people with opioid use disorder receiving opioid substitution therapy in primary care: prospective observational study using linkage between the CPRD and ONS death 11:05 to 11:15 Central square 2 (C2) Matthew Hickman 11:15 Oral presentation Non-medical drug use among prescription drug users 11:15 to 11:25 Central square 2 (C2) Karoliina Karjalainen 11:25 Oral presentation Buprenorphine-Naloxone abuse among participants in a needle exchange programme. A Finnish time-trend study from 2008 to 2018 11:25 to 11:35 Central square 2 (C2) Solja Niemelä